Oronazol (Ketoconazole)

Ketoconazole blocks the fungal enzyme lanosterol 14α‑demethylase, a key step in ergosterol synthesis. Without ergosterol, the fungal cell membrane becomes unstable, inhibiting growth and leading to cell death. This mechanism is effective against a broad range of yeasts and dermatophytes.

The dosage of Oronazol is determined by the prescribing clinician based on the specific infection, patient age, weight and renal or hepatic function. Physicians tailor the regimen to achieve optimal therapeutic effect while minimizing risk, and patients should follow the prescribed instructions exactly.

Ketoconazole is generally contraindicated during pregnancy and lactation because of potential teratogenic effects and drug transfer into breast milk. It should only be used if the expected benefit justifies the possible risk to the fetus or infant, and alternative therapies are preferred when possible.

To order Oronazol, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs) and required import documentation.

Ketoconazole offers a broad spectrum against dermatophytes and yeasts, similar to other azoles such as clotrimazole or fluconazole. Compared with topical agents, oral ketoconazole provides systemic coverage for extensive or resistant infections, but it carries a higher risk of hepatic and endocrine side effects, requiring careful monitoring.

Oronazol should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and avoid storing it in bathrooms or other humid environments.

Oronazol is taken orally, usually with a full glass of water. It may be recommended to ingest the medication with food to reduce gastrointestinal irritation, but patients should follow the specific instructions provided by their healthcare professional.

The most serious adverse effects of ketoconazole include hepatotoxicity, which can manifest as elevated liver enzymes or severe liver injury, and rare but severe skin reactions such as Stevens‑Johnson syndrome. Long‑term use may also suppress adrenal steroid synthesis, leading to adrenal insufficiency.

Oronazol is contraindicated in patients with known hypersensitivity to ketoconazole or other azole antifungals, those with pre‑existing severe liver disease, pregnant or breastfeeding women, and individuals taking medications that strongly interact via the CYP3A4 pathway without appropriate monitoring.